Search

everythinglearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Biologics for severe asthma have known side effects, but some new risks need more study.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Brodalumab is more effective than ustekinumab in treating psoriasis.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.